{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:01:12Z","timestamp":1780311672943,"version":"3.54.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04120-9","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:54:33Z","timestamp":1780304073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracellular vesicles as therapeutic agents for retinal ganglion cell degeneration: current challenges and future prospects"],"prefix":"10.1007","volume":"46","author":[{"given":"Jiaoni","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"6","key":"4120_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00417-022-05556-2","volume":"260","author":"N Zhang","year":"2022","unstructured":"Zhang N, He X, Xing Y, Yang N (2022) Differential susceptibility of retinal ganglion cell subtypes against neurodegenerative diseases. Graefes Arch Clin Exp Ophthalmol 260(6):1807\u20131821","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4120_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108571","volume":"207","author":"J Wang","year":"2021","unstructured":"Wang J, Struebing FL, Geisert EE (2021) Commonalities of optic nerve injury and glaucoma-induced neurodegeneration: Insights from transcriptome-wide studies. Exp Eye Res 207:108571","journal-title":"Exp Eye Res"},{"key":"4120_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020906","author":"T Tsai","year":"2024","unstructured":"Tsai T, Reinehr S, Deppe L, Strubbe A, Kluge N, Dick HB et al (2024) Glaucoma animal models beyond chronic IOP increase. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25020906","journal-title":"Int J Mol Sci"},{"key":"4120_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jconrel.2024.06.029","volume":"372","author":"E Durmaz","year":"2024","unstructured":"Durmaz E, Dribika L, Kutnyanszky M, Mead B (2024) Utilizing extracellular vesicles as a drug delivery system in glaucoma and RGC degeneration. J Control Release 372:209\u2013220","journal-title":"J Control Release"},{"key":"4120_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091584","author":"A Kimura","year":"2016","unstructured":"Kimura A, Namekata K, Guo X, Harada C, Harada T (2016) Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17091584","journal-title":"Int J Mol Sci"},{"key":"4120_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072262","author":"R Boia","year":"2020","unstructured":"Boia R, Ruzafa N, Aires ID, Pereiro X, Ambr\u00f3sio AF, Vecino E et al (2020) Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21072262","journal-title":"Int J Mol Sci"},{"key":"4120_CR7","doi-asserted-by":"crossref","unstructured":"Egunlusi AO, Joubert J (2024) NMDA receptor antagonists: emerging insights into molecular mechanisms and clinical applications in neurological disorders. Pharmaceuticals (Basel) 17(5)","DOI":"10.3390\/ph17050639"},{"issue":"7","key":"4120_CR8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/ceo.13818","volume":"48","author":"F Hui","year":"2020","unstructured":"Hui F, Tang J, Williams PA, McGuinness MB, Hadoux X, Casson RJ et al (2020) Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial. Clin Exp Ophthalmol 48(7):903\u2013914","journal-title":"Clin Exp Ophthalmol"},{"issue":"8","key":"4120_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1089\/jmf.2018.4350","volume":"22","author":"HK Cho","year":"2019","unstructured":"Cho HK, Kim S, Lee EJ, Kee C (2019) Neuroprotective effect of Ginkgo biloba extract against hypoxic retinal ganglion cell degeneration in vitro and in vivo. J Med Food 22(8):771\u2013778","journal-title":"J Med Food"},{"issue":"10","key":"4120_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1041-8","volume":"9","author":"A Osborne","year":"2018","unstructured":"Osborne A, Khatib TZ, Songra L, Barber AC, Hall K, Kong GYX et al (2018) Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor\/tropomyosin-related kinase receptor-B signaling. Cell Death Dis 9(10):1007","journal-title":"Cell Death Dis"},{"issue":"2","key":"4120_CR11","doi-asserted-by":"publisher","first-page":"100010","DOI":"10.1016\/j.preme.2024.100010","volume":"1","author":"V Ravichandiran","year":"2024","unstructured":"Ravichandiran V, Kesharwani A, Anupriya, Bhaskaran M, Parihar VK, Bakhshi S et al (2024) Overcoming biological barriers: precision engineered extracellular vesicles for personalized neuromedicine. Precision Med Eng 1(2):100010","journal-title":"Precision Med Eng"},{"key":"4120_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.875662","volume":"13","author":"L Lambuk","year":"2022","unstructured":"Lambuk L, MohdLazaldin MA, Ahmad S, Iezhitsa I, Agarwal R, Uskokovi\u0107 V et al (2022) Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art. Front Pharmacol 13:875662","journal-title":"Front Pharmacol"},{"key":"4120_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.actbio.2021.11.039","volume":"140","author":"D Wang","year":"2022","unstructured":"Wang D, Lyu Y, Yang Y, Zhang S, Chen G, Pan J et al (2022) Schwann cell-derived EVs facilitate dental pulp regeneration through endogenous stem cell recruitment via SDF-1\/CXCR4 axis. Acta Biomater 140:610\u2013624","journal-title":"Acta Biomater"},{"issue":"1","key":"4120_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-02130-7","volume":"12","author":"AJ da Silva-Junior","year":"2021","unstructured":"da Silva-Junior AJ, Mesentier-Louro LA, Nascimento-Dos-Santos G, Teixeira-Pinheiro LC, Vasques JF, Chimeli-Ormonde L et al (2021) Human mesenchymal stem cell therapy promotes retinal ganglion cell survival and target reconnection after optic nerve crush in adult rats. Stem Cell Res Ther 12(1):69","journal-title":"Stem Cell Res Ther"},{"key":"4120_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biology11060804","author":"MA Di Bella","year":"2022","unstructured":"Di Bella MA (2022) Overview and update on extracellular vesicles: considerations on exosomes and their application in modern medicine. Biology. https:\/\/doi.org\/10.3390\/biology11060804","journal-title":"Biology"},{"key":"4120_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbi.2025.102741","volume":"86","author":"B Davila","year":"2025","unstructured":"Davila B, He B (2025) Extracellular vesicle-mediated RNA warfare: A cross-kingdom battleground. Curr Opin Plant Biol 86:102741","journal-title":"Curr Opin Plant Biol"},{"issue":"1","key":"4120_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202003505","volume":"8","author":"F Teng","year":"2020","unstructured":"Teng F, Fussenegger M (2020) Shedding light on extracellular vesicle biogenesis and bioengineering. Adv Sci (Weinh) 8(1):2003505","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"4120_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.4103\/1673-5374.184448","volume":"11","author":"M Foldvari","year":"2016","unstructured":"Foldvari M, Chen DW (2016) The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy. Neural Regen Res 11(6):875\u2013877","journal-title":"Neural Regen Res"},{"issue":"6","key":"4120_CR19","volume":"17","author":"PC Koya","year":"2025","unstructured":"Koya PC, Kolla SC, Madala V, Sayana SB (2025) Potential of Nerve Growth Factor (NGF)- and Brain-Derived Neurotrophic Factor (BDNF)-targeted gene therapy for Alzheimer\u2019s Disease: a narrative review. Cureus 17(6):e85814","journal-title":"Cureus"},{"issue":"42","key":"4120_CR20","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.2174\/0929867327666200604165451","volume":"27","author":"A Di Stefano","year":"2020","unstructured":"Di Stefano A, Maniscalco M, Balbi B, Ricciardolo FLM (2020) Oxidative and nitrosative stress in the pathogenesis of obstructive lung diseases of increasing severity. Curr Med Chem 27(42):7149\u20137158","journal-title":"Curr Med Chem"},{"key":"4120_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5083876","volume":"2020","author":"E Korbut","year":"2020","unstructured":"Korbut E, Brzozowski T, Magierowski M (2020) Carbon monoxide being hydrogen sulfide and nitric oxide molecular sibling, as endogenous and exogenous modulator of oxidative stress and antioxidative mechanisms in the digestive system. Oxid Med Cell Longev 2020:5083876","journal-title":"Oxid Med Cell Longev"},{"key":"4120_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16030406","author":"J Rodriguez Villanueva","year":"2024","unstructured":"Rodriguez Villanueva J, de la Villa P, Herrero-Vanrell R, Bravo-Osuna I, Guzman-Navarro M (2024) Useful role of a new generation of Dexamethasone, Vitamin E and Human Serum Albumin microparticles in the prevention of excitotoxicity injury in retinal ocular diseases. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics16030406","journal-title":"Pharmaceutics"},{"key":"4120_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.986131","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C, An Y, Xia Z, Zhou X, Li H, Song S et al (2022) The neuroprotective effect of melatonin in glutamate excitotoxicity of R28 cells and mouse retinal ganglion cells. Front Endocrinol (Lausanne) 13:986131","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"4120_CR24","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1089\/neu.2019.6725","volume":"37","author":"LP Evans","year":"2020","unstructured":"Evans LP, Woll AW, Wu S, Todd BP, Hehr N, Hedberg-Buenz A et al (2020) Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes. J Neurotrauma 37(12):1463\u20131480","journal-title":"J Neurotrauma"},{"key":"4120_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110352","volume":"255","author":"D Zhang","year":"2025","unstructured":"Zhang D, Hu F, Li T, Liu H, Li Q, Cheng Y et al (2025) Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity. Exp Eye Res 255:110352","journal-title":"Exp Eye Res"},{"issue":"5","key":"4120_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.18240\/ijo.2023.05.20","volume":"16","author":"ZQ Zhang","year":"2023","unstructured":"Zhang ZQ, Xie Z, Chen SY, Zhang X (2023) Mitochondrial dysfunction in glaucomatous degeneration. Int J Ophthalmol 16(5):811\u2013823","journal-title":"Int J Ophthalmol"},{"key":"4120_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102967","volume":"68","author":"EW B\u00f6hm","year":"2023","unstructured":"B\u00f6hm EW, Buonfiglio F, Voigt AM, Bachmann P, Safi T, Pfeiffer N et al (2023) Oxidative stress in the eye and its role in the pathophysiology of ocular diseases. Redox Biol 68:102967","journal-title":"Redox Biol"},{"key":"4120_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315186","author":"A Merighi","year":"2022","unstructured":"Merighi A, Lossi L (2022) Endoplasmic reticulum stress signaling and neuronal cell death. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232315186","journal-title":"Int J Mol Sci"},{"key":"4120_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.pbr.2015.05.005","volume":"220","author":"H Levkovitch-Verbin","year":"2015","unstructured":"Levkovitch-Verbin H (2015) Retinal ganglion cell apoptotic pathway in glaucoma: initiating and downstream mechanisms. Prog Brain Res 220:37\u201357","journal-title":"Prog Brain Res"},{"issue":"1","key":"4120_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.18240\/ijo.2025.01.20","volume":"18","author":"N Cui","year":"2025","unstructured":"Cui N, Jia J, He Y (2025) Glaucomatous retinal ganglion cells: death and protection. Int J Ophthalmol 18(1):160\u2013167","journal-title":"Int J Ophthalmol"},{"issue":"14","key":"4120_CR31","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.2174\/1381612822666160128144747","volume":"22","author":"CA Gossman","year":"2016","unstructured":"Gossman CA, Christie J, Webster MK, Linn DM, Linn CL (2016) Neuroprotective strategies in glaucoma. Curr Pharm Des 22(14):2178\u20132192","journal-title":"Curr Pharm Des"},{"key":"4120_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216253","author":"HJ Kim","year":"2023","unstructured":"Kim HJ, Cha S, Choi JS, Lee JY, Kim KE, Kim JK et al (2023) scAAV2-mediated expression of Thioredoxin 2 and C3 transferase prevents retinal ganglion cell death and lowers intraocular pressure in a mouse model of glaucoma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242216253","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4120_CR33","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1055\/a-2617-1575","volume":"242","author":"T Qi","year":"2025","unstructured":"Qi T, Liu H, Fr\u00fchn L, L\u00f6w K, Cursiefen C, Prokosch V (2025) Understanding glaucoma: Why it remains a leading cause of blindness worldwide. Klin Monbl Augenheilkd 242(7):712\u2013717","journal-title":"Klin Monbl Augenheilkd"},{"issue":"10","key":"4120_CR34","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/bit.28182","volume":"119","author":"M Bikuna-Izagirre","year":"2022","unstructured":"Bikuna-Izagirre M, Aldazabal J, Extramiana L, Moreno-Montanes J, Carnero E, Paredes J (2022) Technological advances in ocular trabecular meshwork in vitro models for glaucoma research. Biotechnol Bioeng 119(10):2698\u20132714","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"4120_CR35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41598-017-01003-z","volume":"7","author":"X Li","year":"2017","unstructured":"Li X, Zhao F, Xin M, Li G, Luna C, Li G et al (2017) Regulation of intraocular pressure by microRNA cluster miR-143\/145. Sci Rep 7(1):915","journal-title":"Sci Rep"},{"issue":"2","key":"4120_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/ICU.0000000000000829","volume":"33","author":"BN Safa","year":"2022","unstructured":"Safa BN, Wong CA, Ha J, Ethier CR (2022) Glaucoma and biomechanics. Curr Opin Ophthalmol 33(2):80\u201390","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"4120_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250085","volume":"16","author":"DY Park","year":"2021","unstructured":"Park DY, Han JC, Lee EJ, Kee C (2021) Relationship between peripheral vasospasm and visual field progression rates in patients with normal-tension glaucoma with low-teen intraocular pressure. PLoS ONE 16(4):e0250085","journal-title":"PLoS ONE"},{"key":"4120_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100953","volume":"84","author":"DJ Calkins","year":"2021","unstructured":"Calkins DJ (2021) Adaptive responses to neurodegenerative stress in glaucoma. Prog Retin Eye Res 84:100953","journal-title":"Prog Retin Eye Res"},{"key":"4120_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114781","volume":"196","author":"A Hakim","year":"2023","unstructured":"Hakim A, Guido B, Narsineni L, Chen DW, Foldvari M (2023) Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: progress towards non-viral systems. Adv Drug Deliv Rev 196:114781","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4120_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07077-y","volume":"23","author":"M Hu","year":"2025","unstructured":"Hu M, Han Y, Zhang X, Tian S, Shang Z, Yuan Z et al (2025) Extracellular vesicles for targeted drug delivery: advances in surface modification strategies and therapeutic applications. J Transl Med 23(1):1028","journal-title":"J Transl Med"},{"key":"4120_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-67171-6_1","volume":"97","author":"P Fonseka","year":"2021","unstructured":"Fonseka P, Marzan AL, Mathivanan S (2021) Introduction to the Community of Extracellular Vesicles. Subcell Biochem 97:3\u201318","journal-title":"Subcell Biochem"},{"issue":"1","key":"4120_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-025-00724-w","volume":"21","author":"J Meldolesi","year":"2026","unstructured":"Meldolesi J (2026) Microvesicles, exosomes and their combinations with cytoplasmic organelles: from their discovery to their innovative roles in clinical medicine. Biol Direct 21(1):11","journal-title":"Biol Direct"},{"key":"4120_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-0716-2341-1_13","volume":"2504","author":"C Chiozzini","year":"2022","unstructured":"Chiozzini C, Ridolfi B, Federico M (2022) Extracellular Vesicles and Their Use as Vehicles of Immunogens. Methods Mol Biol 2504:177\u2013198","journal-title":"Methods Mol Biol"},{"issue":"2","key":"4120_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1042\/EBC20170078","volume":"62","author":"C D'Souza-Schorey","year":"2018","unstructured":"D\u2019Souza-Schorey C, Schorey JS (2018) Regulation and mechanisms of extracellular vesicle biogenesis and secretion. Essays Biochem 62(2):125\u2013133","journal-title":"Essays Biochem"},{"key":"4120_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2024.109787","volume":"239","author":"Q Yang","year":"2024","unstructured":"Yang Q, Xu Y, Bin X, Chan KP, Chen S, Qian Z et al (2024) Combined treatment of human mesenchymal stem cells and green tea extract on retinal ganglion cell regeneration in rats after optic nerve injury. Exp Eye Res 239:109787","journal-title":"Exp Eye Res"},{"key":"4120_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110505","volume":"258","author":"Y Lu","year":"2025","unstructured":"Lu Y, Guo M, Liu Y, Liu H, Liao M, He K et al (2025) Human induced pluripotent stem cell-derived extracellular vesicles promote neuroprotection effects in rat optic nerve crush model. Exp Eye Res 258:110505","journal-title":"Exp Eye Res"},{"issue":"1","key":"4120_CR47","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13287-024-03926-7","volume":"15","author":"J He","year":"2024","unstructured":"He J, Ao C, Li M, Deng T, Zheng S, Zhang K et al (2024) Clusterin-carrying extracellular vesicles derived from human umbilical cord mesenchymal stem cells restore the ovarian function of premature ovarian failure mice through activating the PI3K\/AKT pathway. Stem Cell Res Ther 15(1):300","journal-title":"Stem Cell Res Ther"},{"key":"4120_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1496101","volume":"2021","author":"Y Ma","year":"2021","unstructured":"Ma Y, Zhou D, Zhang H, Tang L, Qian F, Su J (2021) Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote the proliferation of Schwann cells by regulating the PI3K\/AKT signaling pathway via transferring miR-21. Stem Cells Int 2021:1496101","journal-title":"Stem Cells Int"},{"issue":"1","key":"4120_CR49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13287-020-01702-x","volume":"11","author":"SZ Seyedrazizadeh","year":"2020","unstructured":"Seyedrazizadeh SZ, Poosti S, Nazari A, Alikhani M, Shekari F, Pakdel F et al (2020) Extracellular vesicles derived from human ES-MSCs protect retinal ganglion cells and preserve retinal function in a rodent model of optic nerve injury. Stem Cell Res Ther 11(1):203","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"4120_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12472","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu Y, Sun L, Li Y, Holmes C (2024) Mesenchymal stromal\/stem cell tissue source and in vitro expansion impact extracellular vesicle protein and miRNA compositions as well as angiogenic and immunomodulatory capacities. J Extracell Vesicles 13(8):e12472","journal-title":"J Extracell Vesicles"},{"key":"4120_CR51","doi-asserted-by":"crossref","unstructured":"Sawicki S, Bugno-Poniewierska M, Zurowski J, Szmatola T, Semik-Gurgul E, Bochenek M, et al (2025) Comparative Transcriptome and MicroRNA Profiles of Equine Mesenchymal Stem Cells, Fibroblasts, and Their Extracellular Vesicles. Genes (Basel) 16(8)","DOI":"10.3390\/genes16080936"},{"key":"4120_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040730","author":"B Mathew","year":"2021","unstructured":"Mathew B, Torres LA, Gamboa Acha L, Tran S, Liu A, Patel R et al (2021) Uptake and distribution of administered bone marrow mesenchymal stem cell extracellular vesicles in retina. Cells. https:\/\/doi.org\/10.3390\/cells10040730","journal-title":"Cells"},{"key":"4120_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061746","author":"M Mostafa","year":"2023","unstructured":"Mostafa M, Al Fatease A, Alany RG, Abdelkader H (2023) Recent advances of ocular drug delivery systems: prominence of ocular implants for chronic eye diseases. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15061746","journal-title":"Pharmaceutics"},{"issue":"1","key":"4120_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/jex2.70024","volume":"4","author":"A Qarawani","year":"2025","unstructured":"Qarawani A, Naaman E, Ben-ZviElimelech R, Harel M, Sigal-Dror S, Ben-Zur T et al (2025) Mesenchymal stem cell-derived exosomes mitigate amyloid beta-induced retinal toxicity: Insights from rat model and cellular studies. J Extracell Biol 4(1):e70024","journal-title":"J Extracell Biol"},{"issue":"12","key":"4120_CR55","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1167\/iovs.17-23632","volume":"59","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Bazzazi H, Lima ESR, Pandey NB, Green JJ, Campochiaro PA et al (2018) Three-dimensional transport model for intravitreal and suprachoroidal drug injection. Invest Ophthalmol Vis Sci 59(12):5266\u20135276","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"4120_CR56","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/glia.23579","volume":"67","author":"ID Aires","year":"2019","unstructured":"Aires ID, Boia R, Rodrigues-Neves AC, Madeira MH, Marques C, Ambrosio AF et al (2019) Blockade of microglial adenosine A(2A) receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells. Glia 67(5):896\u2013914","journal-title":"Glia"},{"issue":"12","key":"4120_CR57","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1002\/glia.23880","volume":"68","author":"ID Aires","year":"2020","unstructured":"Aires ID, Ribeiro-Rodrigues T, Boia R, Catarino S, Girao H, Ambrosio AF et al (2020) Exosomes derived from microglia exposed to elevated pressure amplify the neuroinflammatory response in retinal cells. Glia 68(12):2705\u20132724","journal-title":"Glia"},{"key":"4120_CR58","unstructured":"Dwivedi AR, Murti Y, Rawat P, Mahajan S, Kandhari H, Joshi G, et al (2024) Exploring the Insights on Exosomes and their Utility in Treating Ophthalmic Disease: Delving into the Clinical Approval and Present Trials. Curr Drug Deliv"},{"issue":"3","key":"4120_CR59","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1021\/acs.jproteome.0c01048","volume":"20","author":"J Xiao","year":"2021","unstructured":"Xiao J, Zhang H, Yang F, Xiao M, Zhou L, Yu R et al (2021) Proteomic analysis of plasma sEVs reveals that TNFAIP8 is a new biomarker of cell proliferation in diabetic retinopathy. J Proteome Res 20(3):1770\u20131782","journal-title":"J Proteome Res"},{"key":"4120_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110654","volume":"261","author":"HH Louie","year":"2025","unstructured":"Louie HH, Rupenthal ID, Lim JC, Chamley LW, Mugisho OO (2025) Characterisation of vitreous derived small extracellular vesicles in diabetic retinopathy. Exp Eye Res 261:110654","journal-title":"Exp Eye Res"},{"issue":"6","key":"4120_CR61","doi-asserted-by":"publisher","first-page":"36405","DOI":"10.31083\/FBL36405","volume":"30","author":"E Ragni","year":"2025","unstructured":"Ragni E (2025) Extracellular vesicles: recent advances and perspectives. Front Biosci (Landmark Ed) 30(6):36405","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"4120_CR62","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/1381612825666190306153318","volume":"25","author":"M Surman","year":"2019","unstructured":"Surman M, Drozdz A, Stepien E, Przybylo M (2019) Extracellular vesicles as drug delivery systems - methods of production and potential therapeutic applications. Curr Pharm Des 25(2):132\u2013154","journal-title":"Curr Pharm Des"},{"key":"4120_CR63","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fcell.2020.00376","volume":"8","author":"C Dogrammatzis","year":"2020","unstructured":"Dogrammatzis C, Waisner H, Kalamvoki M (2020) Cloaked viruses and viral factors in cutting edge exosome-based therapies. Front Cell Dev Biol 8:376","journal-title":"Front Cell Dev Biol"},{"key":"4120_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cells8060611","author":"FSY Yoshikawa","year":"2019","unstructured":"Yoshikawa FSY, Teixeira FME, Sato MN, Oliveira L (2019) Delivery of microRNAs by extracellular vesicles in viral infections: could the news be packaged? Cells. https:\/\/doi.org\/10.3390\/cells8060611","journal-title":"Cells"},{"issue":"10","key":"4120_CR65","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1248\/bpb.b23-00378","volume":"46","author":"Y Chen","year":"2023","unstructured":"Chen Y, Huang Y, Deng Y, Liu X, Ye J, Li Q et al (2023) Cancer Therapy Empowered by Extracellular Vesicle-Mediated Targeted Delivery. Biol Pharm Bull 46(10):1353\u20131364","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"4120_CR66","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1039\/C7NR06966A","volume":"10","author":"SAA Kooijmans","year":"2018","unstructured":"Kooijmans SAA, Gitz-Francois J, Schiffelers RM, Vader P (2018) Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach. Nanoscale 10(5):2413\u20132426","journal-title":"Nanoscale"},{"key":"4120_CR67","first-page":"338","volume":"52","author":"J Huang","year":"2025","unstructured":"Huang J, Chen H, Li N, Liu P, Yang J, Zhao Y (2025) Emerging technologies towards extracellular vesicles large-scale production. Bioact Mater 52:338\u2013365","journal-title":"Bioact Mater"},{"issue":"12","key":"4120_CR68","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1039\/D3BM00469D","volume":"11","author":"J Johnston","year":"2023","unstructured":"Johnston J, Stone T Jr., Wang Y (2023) Biomaterial-enabled 3D cell culture technologies for extracellular vesicle manufacturing. Biomater Sci 11(12):4055\u20134072","journal-title":"Biomater Sci"},{"issue":"7","key":"4120_CR69","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1007\/s10792-023-02637-x","volume":"43","author":"YY Cong","year":"2023","unstructured":"Cong YY, Fan B, Zhang ZY, Li GY (2023) Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics. Int Ophthalmol 43(7):2575\u20132588","journal-title":"Int Ophthalmol"},{"issue":"2","key":"4120_CR70","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1124\/jpet.115.227223","volume":"355","author":"KN Le","year":"2015","unstructured":"Le KN, Gibiansky L, Good J, Davancaze T, van Lookeren CM, Loyet KM et al (2015) A mechanistic pharmacokinetic\/pharmacodynamic model of factor D inhibition in cynomolgus monkeys by lampalizumab for the treatment of geographic atrophy. J Pharmacol Exp Ther 355(2):288\u2013296","journal-title":"J Pharmacol Exp Ther"},{"key":"4120_CR71","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.2147\/IJN.S502591","volume":"20","author":"X Su","year":"2025","unstructured":"Su X, Wang H, Li Q, Chen Z (2025) Extracellular vesicles: a review of their therapeutic potentials, sources, biodistribution, and administration routes. Int J Nanomedicine 20:3175\u20133199","journal-title":"Int J Nanomedicine"},{"key":"4120_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010546","author":"N Rabienezhad Ganji","year":"2023","unstructured":"Rabienezhad Ganji N, Urzi O, Tinnirello V, Costanzo E, Polito G, Palumbo Piccionello A et al (2023) Proof-of-concept study on the use of tangerine-derived nanovesicles as siRNA delivery vehicles toward colorectal cancer cell line SW480. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25010546","journal-title":"Int J Mol Sci"},{"key":"4120_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109006","author":"H Massoumi","year":"2023","unstructured":"Massoumi H, Amin S, Soleimani M, Momenaei B, Ashraf MJ, Guaiquil VH et al (2023) Extracellular-vesicle-based therapeutics in neuro-ophthalmic disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24109006","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4120_CR74","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1007\/s12672-025-03807-2","volume":"16","author":"M Nourizadeh","year":"2025","unstructured":"Nourizadeh M, Mounesyar SM, Movahhed MS, Alipour K, Zekavatbakhsh R, Hoseinzadeh M et al (2025) Current strategies and novel immunotherapeutic approaches for overcoming immune resistance in glioblastoma. Discov Oncol 16(1):1952","journal-title":"Discov Oncol"},{"key":"4120_CR75","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-1-0716-2341-1_16","volume":"2504","author":"MAC Pomatto","year":"2022","unstructured":"Pomatto MAC, Negro F, Camussi G (2022) Optimized Protocol for Plasma-Derived Extracellular Vesicles Loading with Synthetic miRNA Mimic Using Electroporation. Methods Mol Biol 2504:219\u2013230","journal-title":"Methods Mol Biol"},{"key":"4120_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154813","volume":"250","author":"P Fayyazpour","year":"2023","unstructured":"Fayyazpour P, Fayyazpour A, Abbasi K, Vaez-Gharamaleki Y, Zangbar MS, Raeisi M et al (2023) The role of exosomes in cancer biology by shedding light on their lipid contents. Pathol Res Pract 250:154813","journal-title":"Pathol Res Pract"},{"issue":"5","key":"4120_CR77","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1194\/jlr.TR119000383","volume":"61","author":"AB Ouweneel","year":"2020","unstructured":"Ouweneel AB, Thomas MJ, Sorci-Thomas MG (2020) The ins and outs of lipid rafts: functions in intracellular cholesterol homeostasis, microparticles, and cell membranes: Thematic Review Series: Biology of Lipid Rafts. J Lipid Res 61(5):676\u2013686","journal-title":"J Lipid Res"},{"issue":"1","key":"4120_CR78","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/jcb.29834","volume":"122","author":"GO Skryabin","year":"2021","unstructured":"Skryabin GO, Komelkov AV, Galetsky SA, Bagrov DV, Evtushenko EG, Nikishin II et al (2021) Stomatin is highly expressed in exosomes of different origin and is a promising candidate as an exosomal marker. J Cell Biochem 122(1):100\u2013115","journal-title":"J Cell Biochem"},{"key":"4120_CR79","doi-asserted-by":"publisher","first-page":"32570","DOI":"10.3402\/jev.v5.32570","volume":"5","author":"RA Haraszti","year":"2016","unstructured":"Haraszti RA, Didiot MC, Sapp E, Leszyk J, Shaffer SA, Rockwell HE et al (2016) High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles 5:32570","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"4120_CR80","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1021\/acs.analchem.0c03185","volume":"93","author":"L Dong","year":"2021","unstructured":"Dong L, Huang CY, Johnson EJ, Yang L, Zieren RC, Horie K et al (2021) High-Throughput Simultaneous mRNA Profiling Using nCounter Technology Demonstrates That Extracellular Vesicles Contain Different mRNA Transcripts Than Their Parental Prostate Cancer Cells. Anal Chem 93(8):3717\u20133725","journal-title":"Anal Chem"},{"issue":"10","key":"4120_CR81","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.bbalip.2019.06.010","volume":"1864","author":"M Holopainen","year":"2019","unstructured":"Holopainen M, Colas RA, Valkonen S, Tigistu-Sahle F, Hyvarinen K, Mazzacuva F et al (2019) Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cells. Biochim Biophys Acta Mol Cell Biol Lipids 1864(10):1350\u20131362","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"5\u20136","key":"4120_CR82","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/scd.2023.0229","volume":"33","author":"MC Naskou","year":"2024","unstructured":"Naskou MC, Cochran A, Darzenta N, Golan ME, Stice SL, Martin DR (2024) The Characteristics and Function of Small Extracellular Vesicles Derived from Human Bone Marrow and Umbilical Cord Mesenchymal Stromal Cells Are Influenced by Cell Culture Conditions. Stem Cells Dev 33(5\u20136):117\u2013127","journal-title":"Stem Cells Dev"},{"issue":"4","key":"4120_CR83","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbrc.2016.10.109","volume":"480","author":"K Arisawa","year":"2016","unstructured":"Arisawa K, Mitsudome H, Yoshida K, Sugimoto S, Ishikawa T, Fujiwara Y et al (2016) Saturated fatty acid in the phospholipid monolayer contributes to the formation of large lipid droplets. Biochem Biophys Res Commun 480(4):641\u2013647","journal-title":"Biochem Biophys Res Commun"},{"key":"4120_CR84","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cytogfr.2023.08.006","volume":"73","author":"J Fyfe","year":"2023","unstructured":"Fyfe J, Casari I, Manfredi M, Falasca M (2023) Role of lipid signalling in extracellular vesicles-mediated cell-to-cell communication. Cytokine Growth Factor Rev 73:20\u201326","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"4120_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/jex2.70064","volume":"4","author":"A Brent","year":"2025","unstructured":"Brent A, Shirmast P, McMillan NAJ (2025) Extracellular Vesicle Lipids and Their Role in Delivery. J Extracell Biol 4(6):e70064","journal-title":"J Extracell Biol"},{"key":"4120_CR86","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav8521","author":"OPB Wiklander","year":"2019","unstructured":"Wiklander OPB, Brennan M, L\u00f6tvall J, Breakefield XO, El Andaloussi S (2019) Advances in therapeutic applications of extracellular vesicles. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aav8521","journal-title":"Sci Transl Med"},{"issue":"4","key":"4120_CR87","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/1873-3468.14807","volume":"598","author":"AE Opadele","year":"2024","unstructured":"Opadele AE, Nishioka S, Wu PH, Le QT, Shirato H, Nam JM et al (2024) The lipid-binding D4 domain of perfringolysin O facilitates the active loading of exogenous cargo into extracellular vesicles. FEBS Lett 598(4):446\u2013456","journal-title":"FEBS Lett"},{"issue":"1","key":"4120_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03640-3","volume":"23","author":"J Ramon","year":"2025","unstructured":"Ramon J, Pinheiro C, Vandendriessche C, Lozano-Andres E, De Keersmaecker H, Punj D et al (2025) Pre-formation loading of extracellular vesicles with exogenous molecules using photoporation. J Nanobiotechnol 23(1):556","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4120_CR89","doi-asserted-by":"publisher","first-page":"13344","DOI":"10.1038\/s41598-022-17692-0","volume":"12","author":"Y Watanabe","year":"2022","unstructured":"Watanabe Y, Fukuda T, Hayashi C, Nakao Y, Toyoda M, Kawakami K et al (2022) Extracellular vesicles derived from GMSCs stimulated with TNF-alpha and IFN-alpha promote M2 macrophage polarization via enhanced CD73 and CD5L expression. Sci Rep 12(1):13344","journal-title":"Sci Rep"},{"key":"4120_CR90","doi-asserted-by":"crossref","unstructured":"Santiago JV, Natu A, Ramelow CC, Rayaprolu S, Xiao H, Kumar V, et al (2023) Identification of state-specific proteomic and transcriptomic signatures of microglia-derived extracellular vesicles. bioRxiv","DOI":"10.1101\/2023.07.28.551012"},{"key":"4120_CR91","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtm.2019.01.001","volume":"13","author":"MAC Pomatto","year":"2019","unstructured":"Pomatto MAC, Bussolati B, D\u2019Antico S, Ghiotto S, Tetta C, Brizzi MF et al (2019) Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs. Mol Ther Methods Clin Dev 13:133\u2013144","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"4120_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-025-01407-x","volume":"23","author":"A Esmaeili","year":"2025","unstructured":"Esmaeili A, Esmaeili V, Shahverdi A, Eslaminejad MB (2025) Engineered extracellular vesicles: a breakthrough approach to overcoming sperm cryopreservation challenges. Reprod Biol Endocrinol 23(1):75","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"4120_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801271","volume":"8","author":"MJ Haney","year":"2019","unstructured":"Haney MJ, Klyachko NL, Harrison EB, Zhao Y, Kabanov AV, Batrakova EV (2019) TPP1 delivery to lysosomes with extracellular vesicles and their enhanced brain distribution in the animal model of Batten Disease. Adv Healthc Mater 8(11):e1801271","journal-title":"Adv Healthc Mater"},{"key":"4120_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/jox15020055","author":"S Rawat","year":"2025","unstructured":"Rawat S, Arora S, Dhondale MR, Khadilkar M, Kumar S, Agrawal AK (2025) Stability dynamics of plant-based extracellular vesicles drug delivery. J Xenobiotics. https:\/\/doi.org\/10.3390\/jox15020055","journal-title":"J Xenobiotics"},{"issue":"1","key":"4120_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03768-2","volume":"23","author":"B Li","year":"2025","unstructured":"Li B, Wu W, Xu W, Qian H, Ji C (2025) Advances of extracellular vesicles isolation and detection frontier technology: from heterogeneity analysis to clinical application. J Nanobiotechnol 23(1):678","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4120_CR96","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13287-024-03955-2","volume":"15","author":"F Tang","year":"2024","unstructured":"Tang F, Dong T, Zhou C, Deng L, Liu HB, Wang W et al (2024) Genetically engineered human induced pluripotent stem cells for the production of brain-targeting extracellular vesicles. Stem Cell Res Ther 15(1):345","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"4120_CR97","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.ymthe.2021.10.009","volume":"30","author":"R Zhang","year":"2022","unstructured":"Zhang R, Fu Y, Cheng M, Ma W, Zheng N, Wang Y et al (2022) sEVs(RVG) selectively delivers antiviral siRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV-induced microcephaly in mouse model. Mol Ther 30(5):2078\u20132091","journal-title":"Mol Ther"},{"issue":"46","key":"4120_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202302962","volume":"19","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xia P, Yan F, Yuan M, Yuan H, Du Y et al (2023) Engineered extracellular vesicles for delivery of an IL-1 receptor antagonist promote targeted repair of retinal degeneration. Small 19(46):e2302962","journal-title":"Small"},{"key":"4120_CR99","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.actbio.2025.03.042","volume":"198","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhao J, Ge R, Zhang X, Sun H, Guo Y et al (2025) Arg-Gly-Asp engineered mesenchymal stem cells as targeted nanotherapeutics against kidney fibrosis by modulating m6A. Acta Biomater 198:85\u2013101","journal-title":"Acta Biomater"},{"key":"4120_CR100","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.actbio.2023.12.002","volume":"174","author":"M Abdallah","year":"2024","unstructured":"Abdallah M, Lin L, Styles IK, Morsdorf A, Grace JL, Gracia G et al (2024) Functionalisation of brush polyethylene glycol polymers with specific lipids extends their elimination half-life through association with natural lipid trafficking pathways. Acta Biomater 174:191\u2013205","journal-title":"Acta Biomater"},{"key":"4120_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13237385","author":"O Siontas","year":"2024","unstructured":"Siontas O, Ahn S (2024) Challenges in AAV-based retinal gene therapies and the role of magnetic nanoparticle platforms. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13237385","journal-title":"J Clin Med"},{"issue":"1","key":"4120_CR102","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/17425247.2024.2440099","volume":"22","author":"N Bhom","year":"2025","unstructured":"Bhom N, Somandi K, Ramburrun P, Choonara YE (2025) Extracellular nanovesicles as neurotherapeutics for central nervous system disorders. Expert Opin Drug Deliv 22(1):69\u201384","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"4120_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01075-w","volume":"31","author":"N Putthanbut","year":"2024","unstructured":"Putthanbut N, Lee JY, Borlongan CV (2024) Extracellular vesicle therapy in neurological disorders. J Biomed Sci 31(1):85","journal-title":"J Biomed Sci"},{"key":"4120_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/plants10122762","author":"EA Motolinia-Alcantara","year":"2021","unstructured":"Motolinia-Alcantara EA, Castillo-Araiza CO, Rodriguez-Monroy M, Roman-Guerrero A, Cruz-Sosa F (2021) Engineering considerations to produce bioactive compounds from plant cell suspension culture in bioreactors. Plants. https:\/\/doi.org\/10.3390\/plants10122762","journal-title":"Plants"},{"issue":"1","key":"4120_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-024-01311-2","volume":"23","author":"C Torabi","year":"2024","unstructured":"Torabi C, Choi SE, Pisanic TR, Paulaitis M, Hur SC (2024) Streamlined miRNA loading of surface protein-specific extracellular vesicle subpopulations through electroporation. Biomed Eng Online 23(1):116","journal-title":"Biomed Eng Online"},{"issue":"7","key":"4120_CR106","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1021\/acsbiomaterials.5c00760","volume":"11","author":"SA Lim","year":"2025","unstructured":"Lim SA, Chen S, Suzuki I, Lambaren K, Soleimani A, Ho N et al (2025) Harnessing Microneedles for Delivery and Preservation of Natural Killer Cell-Derived Extracellular Vesicles. ACS Biomater Sci Eng 11(7):4266\u20134278","journal-title":"ACS Biomater Sci Eng"},{"key":"4120_CR107","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4939-6921-0_5","volume":"1590","author":"CJ Hunt","year":"2017","unstructured":"Hunt CJ (2017) Cryopreservation: vitrification and controlled rate cooling. Methods Mol Biol 1590:41\u201377","journal-title":"Methods Mol Biol"},{"issue":"5","key":"4120_CR108","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/24741264211028441","volume":"5","author":"LA Lam","year":"2021","unstructured":"Lam LA, Mehta S, Lad EM, Emerson GG, Jumper JM, Awh CC (2021) Intravitreal injection therapy: current techniques and supplemental services. J Vitreoretin Dis 5(5):438\u2013447","journal-title":"J Vitreoretin Dis"},{"key":"4120_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911769","author":"RM Galindo-Camacho","year":"2022","unstructured":"Galindo-Camacho RM, Blanco-Llamero C, da Ana R, Fuertes MA, Senorans FJ, Silva AM et al (2022) Therapeutic approaches for age-related macular degeneration. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231911769","journal-title":"Int J Mol Sci"},{"key":"4120_CR110","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ajo.2020.12.016","volume":"226","author":"SS Swaminathan","year":"2021","unstructured":"Swaminathan SS, Kunkler AL, Quan AV, Medert CM, Vanner EA, Feuer W et al (2021) Rates of RNFL thinning in patients with suspected or confirmed glaucoma receiving unilateral intravitreal injections for exudative AMD. Am J Ophthalmol 226:206\u2013216","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4120_CR111","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40123-023-00838-2","volume":"13","author":"AF Borkenstein","year":"2024","unstructured":"Borkenstein AF, Borkenstein EM, Langenbucher A (2024) VIVEX: a formula for calculating individual vitreous volume: a new approach towards tailored patient dosing regime in intravitreal therapy. Ophthalmol Ther 13(1):205\u2013219","journal-title":"Ophthalmol Ther"},{"key":"4120_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2022.108092","volume":"63","author":"S Giancaterino","year":"2023","unstructured":"Giancaterino S, Boi C (2023) Alternative biological sources for extracellular vesicles production and purification strategies for process scale-up. Biotechnol Adv 63:108092","journal-title":"Biotechnol Adv"},{"issue":"23","key":"4120_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202503638","volume":"21","author":"CW Hsu","year":"2025","unstructured":"Hsu CW, Fang YC, Li JF, Cheng CA (2025) Decoding complex biological milieus: SHINER\u2019s approach to profiling and functioning of extracellular vesicle subpopulations. Small 21(23):e2503638","journal-title":"Small"},{"key":"4120_CR114","first-page":"23","volume":"163","author":"N Lavon","year":"2018","unstructured":"Lavon N, Zimerman M, Itskovitz-Eldor J (2018) Scalable expansion of pluripotent stem cells. Adv Biochem Eng Biotechnol 163:23\u201337","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"4120_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202502455","author":"X Li","year":"2025","unstructured":"Li X, Wei Y, Li W, Xu R, Xu C, Luo B et al (2025) Acidic pH-triggered membrane fusion enables lyophilized lipid nanoparticles as potent cryoprotectants for human erythrocytes. Adv Healthc Mater. https:\/\/doi.org\/10.1002\/adhm.202502455","journal-title":"Adv Healthc Mater"},{"issue":"7","key":"4120_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0328216","volume":"20","author":"D Sardar","year":"2025","unstructured":"Sardar D, Morol I, Bari J, Sarkar A, Habib A (2025) Optimization of cryoprotectants and storage temperatures for preserving viability and probiotic properties of lyophilized bacterial strains from chicken gut. PLoS ONE 20(7):e0328216","journal-title":"PLoS ONE"},{"key":"4120_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.125071","volume":"669","author":"D Hargrove","year":"2025","unstructured":"Hargrove D, Ranjbar S, Darji M, Nam S, Dawson RJ, Katugampola S et al (2025) Tumor specific delivery and radiation-enhanced tumor penetration of mesoporous silica nanoparticles for effective radionuclide therapy of ovarian peritoneal metastasis. Int J Pharm 669:125071","journal-title":"Int J Pharm"},{"issue":"1","key":"4120_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-020-00745-9","volume":"19","author":"S Swetledge","year":"2021","unstructured":"Swetledge S, Jung JP, Carter R, Sabliov C (2021) Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy. J Nanobiotechnol 19(1):10","journal-title":"J Nanobiotechnol"},{"key":"4120_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105481","volume":"166","author":"M Sarhene","year":"2021","unstructured":"Sarhene M, Ni JY, Duncan ES, Liu Z, Li S, Zhang J et al (2021) Ginsenosides for cardiovascular diseases; update on pre-clinical and clinical evidence, pharmacological effects and the mechanisms of action. Pharmacol Res 166:105481","journal-title":"Pharmacol Res"},{"issue":"33","key":"4120_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202403199","volume":"36","author":"Y Xia","year":"2024","unstructured":"Xia Y, Zhang J, Liu G, Wolfram J (2024) Immunogenicity of extracellular vesicles. Adv Mater 36(33):e2403199","journal-title":"Adv Mater"},{"issue":"46","key":"4120_CR121","doi-asserted-by":"publisher","first-page":"6928","DOI":"10.2174\/1381612822666160923120244","volume":"22","author":"L Ghemtio","year":"2016","unstructured":"Ghemtio L, Xhaard H, Urtti A, Kidron H (2016) Predictive modeling of ocular pharmacokinetics and adverse effects. Curr Pharm Des 22(46):6928\u20136934","journal-title":"Curr Pharm Des"},{"key":"4120_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118911","volume":"194","author":"M Johari","year":"2026","unstructured":"Johari M, Baghban R, Salari R, Attar A (2026) Revolutionizing uveitis treatment with nanotechnology: innovations, barriers, and strategic solutions. Biomed Pharmacother 194:118911","journal-title":"Biomed Pharmacother"},{"key":"4120_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9010041","author":"E Dosmar","year":"2022","unstructured":"Dosmar E, Walsh J, Doyel M, Bussett K, Oladipupo A, Amer S et al (2022) Targeting ocular drug delivery: an examination of local anatomy and current approaches. Bioengineering (Basel). https:\/\/doi.org\/10.3390\/bioengineering9010041","journal-title":"Bioengineering (Basel)"},{"key":"4120_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13010108","author":"HM Kim","year":"2021","unstructured":"Kim HM, Woo SJ (2021) Ocular drug delivery to the retina: current innovations and future perspectives. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13010108","journal-title":"Pharmaceutics"},{"key":"4120_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010134","author":"M L\u00f6scher","year":"2022","unstructured":"L\u00f6scher M, Seiz C, Hurst J, Schnichels S (2022) Topical drug delivery to the posterior segment of the eye. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14010134","journal-title":"Pharmaceutics"},{"issue":"2","key":"4120_CR126","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02516-9","volume":"24","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S (2023) Ocular drug delivery: a comprehensive review. AAPS PharmSciTech 24(2):66","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"4120_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42104-2","volume":"13","author":"M Akkurt Arslan","year":"2023","unstructured":"Akkurt Arslan M, Brignole-Baudouin F, Chardonnet S, Pionneau C, Blond F, Baudouin C et al (2023) Profiling tear film enzymes reveals major metabolic pathways involved in the homeostasis of the ocular surface. Sci Rep 13(1):15231","journal-title":"Sci Rep"},{"key":"4120_CR128","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jtos.2022.06.004","volume":"25","author":"K Kitazawa","year":"2022","unstructured":"Kitazawa K, Inomata T, Shih K, Hughes JB, Bozza N, Tomioka Y et al (2022) Impact of aging on the pathophysiology of dry eye disease: a systematic review and meta-analysis. Ocul Surf 25:108\u2013118","journal-title":"Ocul Surf"},{"issue":"6","key":"4120_CR129","doi-asserted-by":"publisher","first-page":"331","DOI":"10.37349\/ebmx.2024.00023","volume":"1","author":"D Truong","year":"2024","unstructured":"Truong D, Wu KY, Nguyen L, Tran SD (2024) Advancements in hydrogel technology for ocular drug delivery. Explor BioMat-X 1(6):331\u2013352","journal-title":"Explor BioMat-X"},{"key":"4120_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010025","author":"I Ottonelli","year":"2022","unstructured":"Ottonelli I, Bighinati A, Adani E, Loll F, Caraffi R, Vandelli MA et al (2022) Optimization of an injectable hydrogel depot system for the controlled release of retinal-targeted hybrid nanoparticles. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15010025","journal-title":"Pharmaceutics"},{"issue":"5","key":"4120_CR131","doi-asserted-by":"publisher","DOI":"10.1140\/epje\/i2016-16053-2","volume":"39","author":"J Hansing","year":"2016","unstructured":"Hansing J, Ciemer C, Kim WK, Zhang X, DeRouchey JE, Netz RR (2016) Nanoparticle filtering in charged hydrogels: effects of particle size, charge asymmetry and salt concentration. Eur Phys J E Soft Matter 39(5):53","journal-title":"Eur Phys J E Soft Matter"},{"issue":"2","key":"4120_CR132","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/acs.molpharmaceut.0c00411","volume":"18","author":"S Tavakoli","year":"2021","unstructured":"Tavakoli S, Kari OK, Turunen T, Lajunen T, Schmitt M, Lehtinen J et al (2021) Diffusion and Protein Corona Formation of Lipid-Based Nanoparticles in the Vitreous Humor: Profiling and Pharmacokinetic Considerations. Mol Pharm 18(2):699\u2013713","journal-title":"Mol Pharm"},{"issue":"39","key":"4120_CR133","doi-asserted-by":"publisher","first-page":"22018","DOI":"10.1021\/acsami.5b06937","volume":"7","author":"J Pokki","year":"2015","unstructured":"Pokki J, Parmar J, Ergeneman O, Torun H, Guerrero M, Pellicer E et al (2015) Mobility-enhancing coatings for vitreoretinal surgical devices: hydrophilic and enzymatic coatings investigated by microrheology. ACS Appl Mater Interfaces 7(39):22018\u201322028","journal-title":"ACS Appl Mater Interfaces"},{"key":"4120_CR134","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.actbio.2023.09.025","volume":"171","author":"S Lee","year":"2023","unstructured":"Lee S, Hong HK, Song JS, Jeong SI, Chung JY, Woo SJ et al (2023) Intravitreal injectable hydrogel rods with long-acting bevacizumab delivery to the retina. Acta Biomater 171:273\u2013288","journal-title":"Acta Biomater"},{"key":"4120_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109189","volume":"223","author":"CJ Creveling","year":"2022","unstructured":"Creveling CJ, Alsanea Y, Coats B (2022) Correlation of collagen fibril properties and inner limiting membrane thickness with vitreoretinal adhesion in human eyes. Exp Eye Res 223:109189","journal-title":"Exp Eye Res"},{"issue":"5","key":"4120_CR136","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/02713683.2019.1565890","volume":"44","author":"K Peynshaert","year":"2019","unstructured":"Peynshaert K, Devoldere J, Minnaert AK, De Smedt SC, Remaut K (2019) Morphology and composition of the inner limiting membrane: species-specific variations and relevance toward drug delivery research. Curr Eye Res 44(5):465\u2013475","journal-title":"Curr Eye Res"},{"key":"4120_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/cells13090768","author":"K Pluciennik","year":"2024","unstructured":"Pluciennik K, Sicinska P, Misztal W, Bukowska B (2024) Important factors affecting induction of cell death, oxidative stress and DNA damage by nano- and microplastic particles in vitro. Cells. https:\/\/doi.org\/10.3390\/cells13090768","journal-title":"Cells"},{"issue":"2","key":"4120_CR138","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1021\/acs.molpharmaceut.6b00864","volume":"14","author":"J Lee","year":"2017","unstructured":"Lee J, Goh U, Lee HJ, Kim J, Jeong M, Park JH (2017) Effective retinal penetration of lipophilic and lipid-conjugated hydrophilic agents delivered by engineered liposomes. Mol Pharm 14(2):423\u2013430","journal-title":"Mol Pharm"},{"key":"4120_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113849","volume":"384","author":"K De Clerck","year":"2025","unstructured":"De Clerck K, De Smedt S, Remaut K, Peynshaert K (2025) Toward successful retinal drug delivery after intravitreal injection: Current strategies to overcome the inner limiting membrane. J Control Release 384:113849","journal-title":"J Control Release"},{"issue":"1","key":"4120_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-024-01777-0","volume":"12","author":"M Kim","year":"2024","unstructured":"Kim M, Kim JY, Rhim WK, Cimaglia G, Want A, Morgan JE et al (2024) Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection. Acta Neuropathol Commun 12(1):65","journal-title":"Acta Neuropathol Commun"},{"key":"4120_CR141","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jconrel.2023.10.012","volume":"363","author":"S Zhu","year":"2023","unstructured":"Zhu S, Chen L, Wang M, Zhang J, Chen G, Yao Y et al (2023) Schwann cell-derived extracellular vesicles as a potential therapy for retinal ganglion cell degeneration. J Control Release 363:641\u2013656","journal-title":"J Control Release"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04120-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:03:18Z","timestamp":1780308198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04120-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":141,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4120"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04120-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"248"}}